• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-1 降解靶向嵌合体治疗心肌缺血

Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.

机构信息

Department of Bioengineering, College of Engineering, Hanyang University, Seoul 133-791, Korea.

出版信息

Pharm Res. 2010 Oct;27(10):2075-84. doi: 10.1007/s11095-010-0206-7. Epub 2010 Jul 7.

DOI:10.1007/s11095-010-0206-7
PMID:20607367
Abstract

PURPOSE

A hypoxia-inducible VEGF expression system with the oxygen-dependent degradation (ODD) domain was constructed and tested to be used in gene therapy for ischemic myocardial disease.

METHODS

Luciferase and VEGF expression vector systems were constructed with or without the ODD domain: pEpo-SV-Luc (or pEpo-SV-VEGF) and pEpo-SV-Luc-ODD (or pEpo-SV-VEGF-ODD). In vitro gene expression efficiency of each vector type was evaluated in HEK 293 cells under both hypoxic and normoxic conditions. The amount of VEGF protein was estimated by ELISA. The VEGF expression vectors with or without the ODD domain were injected into ischemic rat myocardium. Fibrosis, neovascularization, and cardiomyocyte apoptosis were assessed using Masson's trichrome staining, α-smooth muscle actin (α-SMA) immunostaining, and the TUNEL assay, respectively.

RESULTS

The plasmid vectors containing ODD significantly improved the expression level of VEGF protein in hypoxic conditions. The enhancement of VEGF protein production was attributed to increased protein stability due to oxygen deficiency. In a rat model of myocardial ischemia, the pEpo-SV-VEGF-ODD group exhibited less myocardial fibrosis, higher microvessel density, and less cardiomyocyte apoptosis compared to the control groups (saline and pEpo-SV-VEGF treatments).

CONCLUSION

An ODD-mediated VEGF expression system that facilitates VEGF-production under hypoxia may be useful in the treatment of ischemic heart disease.

摘要

目的

构建并测试了一种具有缺氧诱导型 VEGF 表达系统和氧依赖性降解(ODD)结构域,旨在用于缺血性心肌疾病的基因治疗。

方法

构建了带有或不带有 ODD 结构域的荧光素酶和 VEGF 表达载体系统:pEpo-SV-Luc(或 pEpo-SV-VEGF)和 pEpo-SV-Luc-ODD(或 pEpo-SV-VEGF-ODD)。在体外,在常氧和缺氧条件下,用 HEK 293 细胞评估每种载体类型的基因表达效率。通过 ELISA 估计 VEGF 蛋白的量。将带有或不带有 ODD 结构域的 VEGF 表达载体注射到缺血性大鼠心肌中。通过 Masson 三色染色、α-平滑肌肌动蛋白(α-SMA)免疫染色和 TUNEL 检测分别评估纤维化、新生血管形成和心肌细胞凋亡。

结果

含有 ODD 的质粒载体显著提高了缺氧条件下 VEGF 蛋白的表达水平。VEGF 蛋白产量的增加归因于由于缺氧导致的蛋白稳定性增加。在大鼠心肌缺血模型中,与对照组(生理盐水和 pEpo-SV-VEGF 处理组)相比,pEpo-SV-VEGF-ODD 组的心肌纤维化程度较低,微血管密度较高,心肌细胞凋亡较少。

结论

一种 ODD 介导的 VEGF 表达系统,可在缺氧条件下促进 VEGF 的产生,可能对缺血性心脏病的治疗有用。

相似文献

1
Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.缺氧诱导因子-1 降解靶向嵌合体治疗心肌缺血
Pharm Res. 2010 Oct;27(10):2075-84. doi: 10.1007/s11095-010-0206-7. Epub 2010 Jul 7.
2
Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.缺氧诱导血管内皮生长因子表达用于大鼠脊髓损伤模型的治疗
J Neurosurg Spine. 2007 Jul;7(1):54-60. doi: 10.3171/SPI-07/07/054.
3
Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.通过共转染编码缺氧诱导因子1α的质粒增强促红细胞生成素增强子介导的缺氧诱导基因表达,用于缺血组织靶向基因治疗。
J Drug Target. 2008 Jan;16(1):43-50. doi: 10.1080/10611860701699693.
4
Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.使用水溶性脂质聚合物将缺氧诱导的VEGF基因递送至缺血心肌。
Gene Ther. 2003 Sep;10(18):1535-42. doi: 10.1038/sj.gt.3302034.
5
Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.使用促红细胞生成素增强子和血管内皮生长因子(VEGF)基因治疗的3'非翻译区的缺氧诱导基因表达系统。
J Control Release. 2006 Sep 28;115(1):113-9. doi: 10.1016/j.jconrel.2006.07.010. Epub 2006 Jul 18.
6
Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.缺氧诱导因子基因表达系统中氧依赖降解结构域在血管内皮生长因子基因治疗中的作用。
Spine (Phila Pa 1976). 2009 Dec 15;34(26):E952-8. doi: 10.1097/BRS.0b013e3181c4af80.
7
Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia.缺氧反应性 VEGF 质粒的翻译后调控治疗心肌缺血。
Biomaterials. 2013 Aug;34(26):6229-38. doi: 10.1016/j.biomaterials.2013.04.061. Epub 2013 May 25.
8
Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.在高胆固醇饮食诱导勃起功能障碍的小鼠阴茎海绵体中,使用促红细胞生成素增强子介导的缺氧诱导基因表达系统进行基因治疗。
J Androl. 2012 Sep-Oct;33(5):845-53. doi: 10.2164/jandrol.111.016014. Epub 2012 Mar 8.
9
Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.用于高效分泌的翻译后调控和缺氧响应 VEGF 质粒。
J Control Release. 2012 Jun 28;160(3):525-31. doi: 10.1016/j.jconrel.2012.03.010. Epub 2012 Mar 16.
10
Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy.利用 ATF4 氧依赖性降解结构域进行翻译后调控基因表达,用于缺氧特异性基因治疗。
J Drug Target. 2013 Nov;21(9):830-6. doi: 10.3109/1061186X.2013.829073. Epub 2013 Aug 19.

引用本文的文献

1
Gene Therapy for Cardiovascular Disease: Clinical Perspectives.心血管疾病的基因治疗:临床视角。
Yonsei Med J. 2024 Oct;65(10):557-571. doi: 10.3349/ymj.2024.0127.
2
High Altitude Adaptability and Meat Quality in Tibetan Pigs: A Reference for Local Pork Processing and Genetic Improvement.藏猪的高海拔适应性与肉质:对当地猪肉加工及遗传改良的参考
Animals (Basel). 2019 Dec 3;9(12):1080. doi: 10.3390/ani9121080.
3
Gene expression of vascular endothelial growth factor A and hypoxic adaptation in Tibetan pig.藏猪血管内皮生长因子A的基因表达与低氧适应

本文引用的文献

1
Transcriptional and post-translational regulatory system for hypoxia specific gene expression using the erythropoietin enhancer and the oxygen-dependent degradation domain.利用促红细胞生成素增强子和氧依赖性降解结构域进行缺氧特异性基因表达的转录和翻译后调控系统。
J Control Release. 2007 Aug 28;121(3):218-24. doi: 10.1016/j.jconrel.2007.05.036. Epub 2007 Jun 12.
2
Hypoxic response elements control expression of human vascular endothelial growth factor(165) genes transferred to ischemia myocardium in vivo and in vitro.缺氧反应元件在体内和体外控制转入缺血心肌的人血管内皮生长因子(165)基因的表达。
J Gene Med. 2007 Sep;9(9):788-96. doi: 10.1002/jgm.1070.
3
J Anim Sci Biotechnol. 2016 Apr 2;7:21. doi: 10.1186/s40104-016-0082-z. eCollection 2016.
4
Cardiac Usage of Reducible Poly(oligo-D-arginine) As a Gene Carrier for Vascular Endothelial Growth Factor Expression.可还原聚(寡聚精氨酸)作为血管内皮生长因子表达的基因载体在心脏中的应用。
PLoS One. 2015 Dec 9;10(12):e0144491. doi: 10.1371/journal.pone.0144491. eCollection 2015.
5
Functional polymers of gene delivery for treatment of myocardial infarct.用于治疗心肌梗死的基因递送功能聚合物。
J Control Release. 2014 Dec 10;195:110-9. doi: 10.1016/j.jconrel.2014.07.041. Epub 2014 Jul 27.
6
Contribution of increased VEGF receptors to hypoxic changes in fetal ovine carotid artery contractile proteins.增加的 VEGF 受体对胎儿羊颈动脉收缩蛋白缺氧变化的贡献。
Am J Physiol Cell Physiol. 2013 Apr 1;304(7):C656-65. doi: 10.1152/ajpcell.00110.2012. Epub 2013 Jan 16.
7
Drug delivery systems for the treatment of ischemic stroke.用于治疗缺血性中风的药物输送系统。
Pharm Res. 2013 Oct;30(10):2429-44. doi: 10.1007/s11095-012-0959-2. Epub 2013 Jan 10.
8
Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.促红细胞生成素通过增加心肌血管生成和抑制糖尿病大鼠的间质纤维化来减轻心脏功能障碍。
Cardiovasc Diabetol. 2012 Sep 7;11:105. doi: 10.1186/1475-2840-11-105.
9
Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion.用于高效分泌的翻译后调控和缺氧响应 VEGF 质粒。
J Control Release. 2012 Jun 28;160(3):525-31. doi: 10.1016/j.jconrel.2012.03.010. Epub 2012 Mar 16.
10
The effect of environmental pH on polymeric transfection efficiency.环境 pH 值对聚合物转染效率的影响。
Biomaterials. 2012 Feb;33(5):1651-62. doi: 10.1016/j.biomaterials.2011.11.006. Epub 2011 Nov 29.
Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
使用促红细胞生成素增强子和血管内皮生长因子(VEGF)基因治疗的3'非翻译区的缺氧诱导基因表达系统。
J Control Release. 2006 Sep 28;115(1):113-9. doi: 10.1016/j.jconrel.2006.07.010. Epub 2006 Jul 18.
4
Ischemic injury-specific gene expression in the rat spinal cord injury model using hypoxia-inducible system.使用缺氧诱导系统在大鼠脊髓损伤模型中进行的缺血性损伤特异性基因表达研究
Spine (Phila Pa 1976). 2005 Dec 15;30(24):2729-34. doi: 10.1097/01.brs.0000190395.43772.f3.
5
Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.与缺氧诱导因子-1α氧依赖性降解结构域融合的减毒白喉毒素A的缺氧调节表达优先诱导实体瘤中缺氧细胞的凋亡。
Cancer Res. 2005 Dec 15;65(24):11622-30. doi: 10.1158/0008-5472.CAN-05-0111.
6
Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease.Sp1 依赖性对 RTP801 启动子的调控及其在缺血性疾病的缺氧诱导 VEGF 质粒中的应用。
Pharm Res. 2004 May;21(5):736-41. doi: 10.1023/b:pham.0000026421.09367.b3.
7
Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.缺氧诱导因子(HIF-1)α:其蛋白质稳定性及生物学功能
Exp Mol Med. 2004 Feb 29;36(1):1-12. doi: 10.1038/emm.2004.1.
8
Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system.通过一个灵敏的血红素加氧酶-1质粒系统预防缺血性心脏损伤。
Hypertension. 2004 Apr;43(4):746-51. doi: 10.1161/01.HYP.0000120152.27263.87. Epub 2004 Feb 23.
9
Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.使用水溶性脂质聚合物将缺氧诱导的VEGF基因递送至缺血心肌。
Gene Ther. 2003 Sep;10(18):1535-42. doi: 10.1038/sj.gt.3302034.
10
Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.基因治疗的进展与前景:肢体和心肌缺血的治疗性血管生成
Gene Ther. 2003 Feb;10(4):285-91. doi: 10.1038/sj.gt.3301969.